Skip to main content

Birth Control News (Page 5)

Related terms: Fertility Control, Anticonception

More American Men Now Opting for Vasectomy

THURSDAY, Aug. 31, 2023 – Vasectomies are becoming more common in the United States, with rates surging by more than one-quarter during the past decade, a recent study reveals. The U.S. vasectomy...

First-Time Dads Often Experience Dip in Relationship Satisfaction

THURSDAY, Aug. 31, 2023 – Most fathers experience a decline in relationship satisfaction that can last for years after the baby is born, new research shows. “A good couple relationship during the t...

No 'Beer Goggles': Drinking Doesn't Make Others Seem More Attractive, Study Finds

WEDNESDAY, Aug. 30, 2023 – Many a person has blamed "beer goggles" following a regrettable one-night stand, but a new study suggests that there's no such thing. Rather, alcohol acts more like...

Vasectomy Rate Increased in U.S. Men From 2014 to 2021

TUESDAY, Aug. 29, 2023 – Vasectomy rates increased in the United States from 2014 to 2021 among privately insured men, according to a study recently published online in Urology. Zhong Huang, from...

Mistreatment During Maternity Care Affects 20%

WEDNESDAY, Aug. 23, 2023 – About one in five women report mistreatment during maternity care, with mistreatment reported more often by Black, Hispanic, and multiracial respondents, according to a...

COVID-19 Recession Resulted in 'Baby Bump'

TUESDAY, Aug. 22, 2023 – The COVID-19 recession resulted in an overall baby bump, or increase in births, among U.S.-born mothers, according to a study published online Aug. 15 in the Proceedings of...

'Reduced Effectiveness'; Some Lots of Tydemy Recalled

WEDNESDAY, Aug. 2, 2023 – Certain lots of the prescription birth control pill Tydemy may be less effective than expected, potentially resulting in an unintended pregnancy, because the pills do not...

Some Lots of Tydemy Birth Control Pills Recalled Due to 'Reduced Effectiveness'

WEDNESDAY, Aug. 2, 2023 – Certain lots of the prescription birth control pill Tydemy may be less effective than expected, potentially resulting in an unintended pregnancy, because the pills do not...

USPSTF Recommends Folic Acid Supplement Before, During Pregnancy

TUESDAY, Aug. 1, 2023 – The U.S Preventive Services Task Force (USPSTF) recommends folic acid supplementation for people planning to or who could become pregnant. These recommendations form the...

FDA Medwatch Alert: Lupin Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of 2 Lots of Tydemy Due to Out of Specification (OOS) Results at the 12-month Stability Time Point

Baltimore, Maryland, July 28, 2023: Lupin Pharmaceuticals Inc. (Lupin) is voluntarily recalling two (2) lots of Tydemy (Drospirenone, Ethinyl Estradiol and Levomefolate Calcium Tablets...

Oxycodone Does Not Increase Risk for Persistent Opioid Use After Delivery

MONDAY, July 31, 2023 – Initiation of oxycodone versus codeine is not associated with an increased risk for persistent opioid use after delivery overall, but increased risk is seen after vaginal...

FDA Approves Opill (norgestrel) OTC Daily Oral Contraceptive

DUBLIN, July 13, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, announced today that the U.S. Food and Drug Administration (FDA) approved ...

FDA Approves Medicines360’s Liletta (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Eight Years

SAN FRANCISCO – Nov. 14, 2022 – Medicines360, a global nonprofit organization with a mission to expand women’s access to quality medicines, announced today that the U.S. Food and Drug Administration ...

FDA Approves Extension of Mirena (levonorgestrel-releasing intrauterine system) Intrauterine Device (IUD) for up to Eight Years of Pregnancy Prevention

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer, a leader in women's healthcare, announced today that the U.S. Food and Drug Administration (FDA) approved a supplemental new drug application (sNDA) that...

FDA Approves Nextstellis (drospirenone and estetrol) Oral Contraceptive for Birth Control

GREENVILLE, N.C., April 16, 2021 /PRNewswire/ – Mayne Pharma announced today that the U.S. Food and Drug Administration (FDA) has approved Nextstellis (3 mg drospirenone [DRSP] and 14.2 mg estetrol...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Emergency Contraception, Postcoital Contraception

Related drug support groups

Depo-Provera, Nexplanon, Provera, NuvaRing, Mirena, Implanon, levonorgestrel, Sprintec, Loestrin 24 Fe, Yasmin, Lo Loestrin Fe, medroxyprogesterone, Kyleena